incethe mid-1980s. The standard treatment for osteosarcoma is tumor r...About IDM Pharma ...IDM Pharma is focused on the development of innovative cancer products...For more information about the company and its products visitA HREF...Forward-Looking Statements ...

ince
the mid-1980s. The standard treatment for osteosarcoma is tumor resection
with combination chemotherapy before and after surgery.

About IDM Pharma

IDM Pharma is focused on the development of innovative cancer products
that either destroy cancer cells by activating the immune system or prevent
tumor recurrence by triggering a specific adaptive immune response. IDM
Pharma is dedicated to maximizing the full therapeutic and commercial
potential of each of its innovative products to address the needs of
patients and the physicians who treat these patients.

This press release includes forward-looking statements that reflect
management's current views of future events including the objectives of the
compassionate access study, the Company's plans to address the remaining
questions with respect to the MAA during the clock-stop granted by the
CHMP, and the expected timing of a final opinion from the CHMP and of a
final regulatory decision regarding the MAA in the European Union, as well
as the Company's plans to collect, analyze and submit additional Phase 3
data in an amended NDA for L-MTP-PE, including the expected timing for such
an amended NDA, and to respond to other matters raised by the FDA and plans
to evaluate strategic alternatives. Actual results may differ materially
from the forward- looking statements due to a number of important factors,
including, but not limited to, whether the compassionate access study will
generate data that is consistent with data from previous studies with
L-MTP-PE or result in improvement in disease control and quality of life
for participants in the study, whether the Company will be able to provide
assurance regarding the quality of the existing data and to respond to the
remaining issues with regard to the MAA, including ver'/>"/>

(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today announced that Robert ... Directors. "Bob is an ardent champion for innovation ... privilege to have him on Edwards, board as we pursue ... Edwards, chairman and CEO. "Bob has provided a valuable perspective ...

(Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced that it ... Bronx campus. The goal is to bring this Torah – dating from 1880 – ... rituals and religious services. , Scroll No. 515, from the town of Taus-Domazlice, ...

(Date:8/1/2015)... ... , ... On Tuesday, July 28th, Symantec released a security industry whitepaper ... the attack on Anthem Inc. which resulted in one of the largest data breaches ... spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO of ...

(Date:8/1/2015)... ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the Executive ... the Appalachian Trail by stepping off Springer Mountain and heading north. Since that ... 26th Phil reached Connecticut and was greeted by friends and family. He visited CCAR ...

... Healthy Kitchen, Healthy Lives engages a variety of health ... at The Culinary Institute of America , Greystone ... education conference that fosters a connection between nutrition science, ... Wellness Council is a participant in the event which ...

... Autism Awareness Day VILLANOVA, Pa. and 15 Centers Nationwide, April ... the likelihood of an autism diagnosis is four times that of ... than with cancer, diabetes and AIDS combined, yet startlingly, many parents ... in their children or where to turn for help when those ...

... 2009 (BRONX, NY) Scientists at Albert Einstein College ... theory of autism that suggests that the brains of people ... the disorder might be reversible. , The central ... Brain Research Reviews , is that autism is a ...

... Sutter Health network of doctors, hospitals and other health ... health care quality according to the respected Lewin Group, ... The Lewin Group produces rankings of America,s 120 largest ... satisfaction data from 2007, as reported by the Centers ...

... April 1 Edifecs announced ... implementation issues that providers, payers, clearinghouses and other healthcare ... new standards. In these sessions, Edifecs will offer ... Edifecs5010(TM) Migration -- a comprehensive set of products, online ...

... levels of nutrients found to ... health in the AREDS clinical ... Eye Institute. MacularProtect also delivers ... antioxidant found to play an ...

Oculair (re-formulated Syntrx Complete) is a potent full-spectrum multiple vitamin/mineral/antioxidant dietary supplement that supports the normal aging process. It is designed to reflect the most re...

Ocuvite® Lutein is an advanced antioxidant supplement formulated to provide nutritional support for the eye....